Joana Goncalves
Keine laufenden Positionen mehr
Vermögen: 48 562 $ am 31.03.2024
Profil
Joana Goncalves worked as the Vice President-Medical Affairs & Neurology at Celgene Corp.
from 2014 to 2018.
Prior to that, she was the VP-Medical Strategy & Scientific Affairs at Leo Pharma, Inc. from 2012 to 2014.
Currently, she is serving as the Chief Medical Officer at CARA Therapeutics, Inc. since 2018.
Dr. Goncalves holds a doctorate degree from the University of Cape Town.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CARA THERAPEUTICS INC
0,10% | 05.04.2024 | 53 365 ( 0,10% ) | 48 562 $ | 31.03.2024 |
Ehemalige bekannte Positionen von Joana Goncalves
| Unternehmen | Position | Ende |
|---|---|---|
| CARA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 16.04.2024 |
| CELGENE | Chief Tech/Sci/R&D Officer | 01.10.2018 |
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Chief Tech/Sci/R&D Officer | 01.04.2014 |
Ausbildung von Joana Goncalves
| University of Cape Town | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CARA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Retail Trade |
